Global Locator
Genzyme Websites
Health Care Professionals
Company
Products
Research
Patients
Responsibility
Careers
News
About Genzyme
Company Leadership
Business Units
News
Press Contacts
Subscribe to News
Recognition and Awards
Working With Genzyme
Global Reach
Download Genzyme Materials
April 24, 2012 02:45 PM Eastern Daylight Time
Significant Improvement in Disability Scores Observed in Multiple Sclerosis Patients Who Received LemtradaTM* (Alemtuzumab) Compared With Rebif® in Phase III Trial
Genzyme Brochure
Download
Adobe PDF
772.6 KB
Smart Multimedia Gallery
Clinical Overview
View and Share Document
Download Adobe PDF
Genzyme Brochure
View and Share Logo
Download Small
Share
Facebook
Twitter
LinkedIn
Delicious
Reddit
StumbleUpon
Digg
MySpace
Newsvine
Google Bookmark
Yahoo! Bookmark
Email
All News
|
News with Multimedia
>
Press Release: Significant Improvement in Disability Scores Ob...
infoBox
LinkedIn
Yahoo! Buzz
Facebook
Twitter
Delicious
DIGG